TSH Biopharm Corporation Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 126.7 million compared to TWD 109.62 million a year ago. Net income was TWD 18.28 million compared to TWD 16.28 million a year ago. Basic earnings per share from continuing operations was TWD 0.48 compared to TWD 0.42 a year ago. Diluted earnings per share from continuing operations was TWD 0.48 compared to TWD 0.42 a year ago.
For the six months, sales was TWD 244.17 million compared to TWD 230.07 million a year ago. Net income was TWD 28.96 million compared to TWD 35.7 million a year ago. Basic earnings per share from continuing operations was TWD 0.75 compared to TWD 0.93 a year ago. Diluted earnings per share from continuing operations was TWD 0.75 compared to TWD 0.93 a year ago.